To be protected against Delta variant, a third dose is needed for Coronavac – study

Three out of four people who had received the product had neutralizing antibodies six months after the full treatment but after that point, the defenses against Covid-19 tend to diminish, particularly regarding new variants

RIO DE JANEIRO, BRAZIL - A study by Chile's Catholic University has shown that the Chinese-developed Coronavac vaccine's effectiveness declines after six months, so patients may need a third dose of the immunizer.

Three out of four people who had received the vaccine still had neutralizing antibodies six months after the full treatment; however, after that point, the defenses against Covid-19 tend to disappear, particularly regarding new variants.

Coronavac protection is at its peak two weeks after the second dose and 42 days after the first one, but the levels of antibodies begin to fall from that . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?